Matthew R. Henn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew R. Henn has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Bruce W. Birren
Broad Institute of MIT & Harvard, Cambridge, Massachusetts, United States of America
3 shared publications- Niall J. Lennon
Broad Clinical Labs, Broad Institute
3 shared publications Alexander R. Macalalad
Broad Institute of MIT & Harvard, Cambridge, Massachusetts, USA
2 shared publications- Elizabeth Ryan
The Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
2 shared publications - Joshua Z. Levin
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, USA
2 shared publications Michael C. Zody
Broad Institute of MIT & Harvard, Cambridge, Massachusetts, United States of America
2 shared publications
Latest Publications
- Open Access
- 15 March 2012
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 8 (3) , e1002417
Highly Sensitive and Specific Detection of Rare Variants in Mixed Viral Populations from Massively Parallel Sequence Data
Viruses diversify over time within hosts, often undercutting the effectiveness of host defenses and therapeutic interventions. To design successful vaccines and therapeutics, it is critical to better understand viral diversification, including comprehensively characterizing the genetic variants in viral intra-host populations and modeling changes from transmission through the course of infection. Massively parallel sequencing technologies can overcome the cost constraints of older sequencing methods and obtain the high sequence coverage needed to detect rare genetic variants (97% sensitivity and >97% specificity on control read sets. On data derived from a patient after four years of HIV-1 infection, V-Phaser detected 2,015 variants across the ∼10 kb genome, including 603 rare variants (V-Phaser identified variants at frequencies down to 0.2%, comparable to the detection threshold of allele-specific PCR, a method that requires prior knowledge of the variants. The high sensitivity and specificity of V-Phaser enables identifying and tracking changes in low frequency variants in mixed populations such as RNA viruses. New sequencing technologies provide unprecedented resolution to study pathogen populations, such as the single stranded RNA viruses HIV, dengue (DENV), and West Nile (WNV), and how they evolve within infected individuals in response to immune, therapeutic, and vaccine pressures. While these new technologies provide high volumes of data, these data contain process errors. To detect biological variants, especially those occurring at low frequencies in the population, these technologies require a method to differentiate biological variants from process errors with high sensitivity and specificity. To address this challenge, we introduce the V-Phaser algorithm, which distinguished the covariation of biological variants from that of process errors. We validate the method by measuring how frequently it correctly identifies variants and errors on actual read sets with known variation. Further, using data derived from a patient following four years of HIV-1 infection, we show that V-Phaser can detect biological variants at frequencies comparable to approaches that require prior knowledge. V-Phaser is available for download at: http://www.broadinstitute.org/scientific-community/software.
- 15 March 2012
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 8 (3) , e1002417
Open AccessHighly Sensitive and Specific Detection of Rare Variants in Mixed Viral Populations from Massively Parallel Sequence Data
Viruses diversify over time within hosts, often undercutting the effectiveness of host defenses and therapeutic interventions. To design successful vaccines and therapeutics, it is critical to better understand viral diversification, including comprehensively characterizing the genetic variants in viral intra-host populations and modeling changes from transmission through the course of infection. Massively parallel sequencing technologies can overcome the cost constraints of older sequencing methods and obtain the high sequence coverage needed to detect rare genetic variants (97% sensitivity and >97% specificity on control read sets. On data derived from a patient after four years of HIV-1 infection, V-Phaser detected 2,015 variants across the ∼10 kb genome, including 603 rare variants (V-Phaser identified variants at frequencies down to 0.2%, comparable to the detection threshold of allele-specific PCR, a method that requires prior knowledge of the variants. The high sensitivity and specificity of V-Phaser enables identifying and tracking changes in low frequency variants in mixed populations such as RNA viruses. New sequencing technologies provide unprecedented resolution to study pathogen populations, such as the single stranded RNA viruses HIV, dengue (DENV), and West Nile (WNV), and how they evolve within infected individuals in response to immune, therapeutic, and vaccine pressures. While these new technologies provide high volumes of data, these data contain process errors. To detect biological variants, especially those occurring at low frequencies in the population, these technologies require a method to differentiate biological variants from process errors with high sensitivity and specificity. To address this challenge, we introduce the V-Phaser algorithm, which distinguished the covariation of biological variants from that of process errors. We validate the method by measuring how frequently it correctly identifies variants and errors on actual read sets with known variation. Further, using data derived from a patient following four years of HIV-1 infection, we show that V-Phaser can detect biological variants at frequencies comparable to approaches that require prior knowledge. V-Phaser is available for download at: http://www.broadinstitute.org/scientific-community/software.
- Open Access
- 1 January 2012
- Published by Springer Nature in BMC Genomics
- Vol. 13 (1) , 475
De novo assembly of highly diverse viral populations
Extensive genetic diversity in viral populations within infected hosts and the divergence of variants from existing reference genomes impede the analysis of deep viral sequencing data. A de novo population consensus assembly is valuable both as a single linear representation of the population and as a backbone on which intra-host variants can be accurately mapped. The availability of consensus assemblies and robustly mapped variants are crucial to the genetic study of viral disease progression, transmission dynamics, and viral evolution. Existing de novo assembly techniques fail to robustly assemble ultra-deep sequence data from genetically heterogeneous populations such as viruses into full-length genomes due to the presence of extensive genetic variability, contaminants, and variable sequence coverage.
- 1 January 2012
- Published by Springer Nature in BMC Genomics
- Vol. 13 (1) , 475
Open AccessDe novo assembly of highly diverse viral populations
Extensive genetic diversity in viral populations within infected hosts and the divergence of variants from existing reference genomes impede the analysis of deep viral sequencing data. A de novo population consensus assembly is valuable both as a single linear representation of the population and as a backbone on which intra-host variants can be accurately mapped. The availability of consensus assemblies and robustly mapped variants are crucial to the genetic study of viral disease progression, transmission dynamics, and viral evolution. Existing de novo assembly techniques fail to robustly assemble ultra-deep sequence data from genetically heterogeneous populations such as viruses into full-length genomes due to the presence of extensive genetic variability, contaminants, and variable sequence coverage.
- 21 December 2011
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (114) , 114ra128
Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity
The complex interactions between serotype-specific immunity and viral genetics drive dengue disease outcomes in endemic populations.
- 21 December 2011
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (114) , 114ra128
Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity
The complex interactions between serotype-specific immunity and viral genetics drive dengue disease outcomes in endemic populations.
- Open Access
- 11 July 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 54 (4) , 1157-1166
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations
Human leukocyte antigen B27 is associated with spontaneous viral clearance in hepatitis C virus (HCV) infection. Viral escape within the immunodominant, HLA-B27-restricted, HCV-specific, cluster of differentiation (CD)8+ T-cell epitope, nonstructural protein (NS)5B2841-2849 (ARMILMTHF), has been shown to be limited by viral fitness costs as well as broad T-cell cross-recognition, suggesting a potential mechanism of protection by HLA-B27. Here, we studied the subdominant HLA-B27-restricted epitope, NS5B2936-2944 (GRAAICGKY), to further define the mechanisms of protection by HLA-B27. We identified a unique pattern of escape mutations within this epitope in a large cohort of HCV genotype 1a–infected patients. The predominant escape mutations represented conservative substitutions at the main HLA-B27 anchor residue or a T-cell receptor contact site, neither of which impaired viral replication capacity, as assessed in a subgenomic HCV replicon system. In contrast, however, in a subset of HLA-B27+ subjects, rare escape mutations arose at the HLA-B27 anchor residue, R2937, which nearly abolished viral replication. Notably, these rare mutations only occurred in conjunction with the selection of two equally rare, and structurally proximal, upstream mutations. Coexpression of these upstream mutations with the rare escape mutations dramatically restored viral replication capacity from Conclusion: The selection of rare CTL escape mutations in this HLA-B27-restricted epitope dramatically impairs viral replicative fitness, unless properly compensated. These data support a role for the targeting of highly constrained regions by HLA-B27 in its ability to assert immune control of HCV and other highly variable pathogens. (Hepatology 2011;)
- 11 July 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 54 (4) , 1157-1166
Open AccessHuman leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations
Human leukocyte antigen B27 is associated with spontaneous viral clearance in hepatitis C virus (HCV) infection. Viral escape within the immunodominant, HLA-B27-restricted, HCV-specific, cluster of differentiation (CD)8+ T-cell epitope, nonstructural protein (NS)5B2841-2849 (ARMILMTHF), has been shown to be limited by viral fitness costs as well as broad T-cell cross-recognition, suggesting a potential mechanism of protection by HLA-B27. Here, we studied the subdominant HLA-B27-restricted epitope, NS5B2936-2944 (GRAAICGKY), to further define the mechanisms of protection by HLA-B27. We identified a unique pattern of escape mutations within this epitope in a large cohort of HCV genotype 1a–infected patients. The predominant escape mutations represented conservative substitutions at the main HLA-B27 anchor residue or a T-cell receptor contact site, neither of which impaired viral replication capacity, as assessed in a subgenomic HCV replicon system. In contrast, however, in a subset of HLA-B27+ subjects, rare escape mutations arose at the HLA-B27 anchor residue, R2937, which nearly abolished viral replication. Notably, these rare mutations only occurred in conjunction with the selection of two equally rare, and structurally proximal, upstream mutations. Coexpression of these upstream mutations with the rare escape mutations dramatically restored viral replication capacity from Conclusion: The selection of rare CTL escape mutations in this HLA-B27-restricted epitope dramatically impairs viral replicative fitness, unless properly compensated. These data support a role for the targeting of highly constrained regions by HLA-B27 in its ability to assert immune control of HCV and other highly variable pathogens. (Hepatology 2011;)
- Open Access
- 18 January 2011
- Published by Springer Nature in BMC Genomics
- Vol. 12 (1) , 42
Next-generation sequencing for HLA typing of class I loci
Background: Comprehensive sequence characterization across the MHC is important for successful organ transplantation and genetic association studies. To this end, we have developed an automated sample preparation, molecular barcoding and multiplexing protocol for the amplification and sequence-determination of class I HLA loci. We have coupled this process to a novel HLA calling algorithm to determine the most likely pair of alleles at each locus. Results: We have benchmarked our protocol with 270 HapMap individuals from four worldwide populations with 96.4% accuracy at 4-digit resolution. A variation of this initial protocol, more suitable for large sample sizes, in which molecular barcodes are added during PCR rather than library construction, was tested on 95 HapMap individuals with 98.6% accuracy at 4-digit resolution. Conclusions: Next-generation sequencing on the 454 FLX Titanium platform is a reliable, efficient, and scalable technology for HLA typing.
- 18 January 2011
- Published by Springer Nature in BMC Genomics
- Vol. 12 (1) , 42
Open AccessNext-generation sequencing for HLA typing of class I loci
Background: Comprehensive sequence characterization across the MHC is important for successful organ transplantation and genetic association studies. To this end, we have developed an automated sample preparation, molecular barcoding and multiplexing protocol for the amplification and sequence-determination of class I HLA loci. We have coupled this process to a novel HLA calling algorithm to determine the most likely pair of alleles at each locus. Results: We have benchmarked our protocol with 270 HapMap individuals from four worldwide populations with 96.4% accuracy at 4-digit resolution. A variation of this initial protocol, more suitable for large sample sizes, in which molecular barcodes are added during PCR rather than library construction, was tested on 95 HapMap individuals with 98.6% accuracy at 4-digit resolution. Conclusions: Next-generation sequencing on the 454 FLX Titanium platform is a reliable, efficient, and scalable technology for HLA typing.
- Open Access
- 5 February 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9083
Analysis of High-Throughput Sequencing and Annotation Strategies for Phage Genomes
Bacterial viruses (phages) play a critical role in shaping microbial populations as they influence both host mortality and horizontal gene transfer. As such, they have a significant impact on local and global ecosystem function and human health. Despite their importance, little is known about the genomic diversity harbored in phages, as methods to capture complete phage genomes have been hampered by the lack of knowledge about the target genomes, and difficulties in generating sufficient quantities of genomic DNA for sequencing. Of the approximately 550 phage genomes currently available in the public domain, fewer than 5% are marine phage. To advance the study of phage biology through comparative genomic approaches we used marine cyanophage as a model system. We compared DNA preparation methodologies (DNA extraction directly from either phage lysates or CsCl purified phage particles), and sequencing strategies that utilize either Sanger sequencing of a linker amplification shotgun library (LASL) or of a whole genome shotgun library (WGSL), or 454 pyrosequencing methods. We demonstrate that genomic DNA sample preparation directly from a phage lysate, combined with 454 pyrosequencing, is best suited for phage genome sequencing at scale, as this method is capable of capturing complete continuous genomes with high accuracy. In addition, we describe an automated annotation informatics pipeline that delivers high-quality annotation and yields few false positives and negatives in ORF calling. These DNA preparation, sequencing and annotation strategies enable a high-throughput approach to the burgeoning field of phage genomics.
- 5 February 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9083
Open AccessAnalysis of High-Throughput Sequencing and Annotation Strategies for Phage Genomes
Bacterial viruses (phages) play a critical role in shaping microbial populations as they influence both host mortality and horizontal gene transfer. As such, they have a significant impact on local and global ecosystem function and human health. Despite their importance, little is known about the genomic diversity harbored in phages, as methods to capture complete phage genomes have been hampered by the lack of knowledge about the target genomes, and difficulties in generating sufficient quantities of genomic DNA for sequencing. Of the approximately 550 phage genomes currently available in the public domain, fewer than 5% are marine phage. To advance the study of phage biology through comparative genomic approaches we used marine cyanophage as a model system. We compared DNA preparation methodologies (DNA extraction directly from either phage lysates or CsCl purified phage particles), and sequencing strategies that utilize either Sanger sequencing of a linker amplification shotgun library (LASL) or of a whole genome shotgun library (WGSL), or 454 pyrosequencing methods. We demonstrate that genomic DNA sample preparation directly from a phage lysate, combined with 454 pyrosequencing, is best suited for phage genome sequencing at scale, as this method is capable of capturing complete continuous genomes with high accuracy. In addition, we describe an automated annotation informatics pipeline that delivers high-quality annotation and yields few false positives and negatives in ORF calling. These DNA preparation, sequencing and annotation strategies enable a high-throughput approach to the burgeoning field of phage genomics.
- Open Access
- 5 February 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (2) , R15
A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454
We present an automated, high throughput library construction process for 454 technology. Sample handling errors and cross-contamination are minimized via end-to-end barcoding of plasticware, along with molecular DNA barcoding of constructs. Automation-friendly magnetic bead-based size selection and cleanup steps have been devised, eliminating major bottlenecks and significant sources of error. Using this methodology, one technician can create 96 sequence-ready 454 libraries in 2 days, a dramatic improvement over the standard method.
- 5 February 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (2) , R15
Open AccessA scalable, fully automated process for construction of sequence-ready barcoded libraries for 454
We present an automated, high throughput library construction process for 454 technology. Sample handling errors and cross-contamination are minimized via end-to-end barcoding of plasticware, along with molecular DNA barcoding of constructs. Automation-friendly magnetic bead-based size selection and cleanup steps have been devised, eliminating major bottlenecks and significant sources of error. Using this methodology, one technician can create 96 sequence-ready 454 libraries in 2 days, a dramatic improvement over the standard method.